JP2016506905A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016506905A5 JP2016506905A5 JP2015552077A JP2015552077A JP2016506905A5 JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5 JP 2015552077 A JP2015552077 A JP 2015552077A JP 2015552077 A JP2015552077 A JP 2015552077A JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5
- Authority
- JP
- Japan
- Prior art keywords
- azide
- saccharide
- group
- spacer
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1300707.5 | 2013-01-15 | ||
| GBGB1300707.5A GB201300707D0 (en) | 2013-01-15 | 2013-01-15 | Compounds and processes |
| PCT/EP2014/050483 WO2014111344A1 (en) | 2013-01-15 | 2014-01-13 | Cycloalkyne derivatized saccharides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018246761A Division JP2019073528A (ja) | 2013-01-15 | 2018-12-28 | シクロアルキン誘導体化糖類 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016506905A JP2016506905A (ja) | 2016-03-07 |
| JP2016506905A5 true JP2016506905A5 (enExample) | 2017-02-09 |
| JP6719209B2 JP6719209B2 (ja) | 2020-07-08 |
Family
ID=47758014
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015552077A Active JP6719209B2 (ja) | 2013-01-15 | 2014-01-13 | シクロアルキン誘導体化糖類 |
| JP2018246761A Withdrawn JP2019073528A (ja) | 2013-01-15 | 2018-12-28 | シクロアルキン誘導体化糖類 |
| JP2020050828A Active JP7036854B2 (ja) | 2013-01-15 | 2020-03-23 | シクロアルキン誘導体化糖類 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018246761A Withdrawn JP2019073528A (ja) | 2013-01-15 | 2018-12-28 | シクロアルキン誘導体化糖類 |
| JP2020050828A Active JP7036854B2 (ja) | 2013-01-15 | 2020-03-23 | シクロアルキン誘導体化糖類 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11135300B2 (enExample) |
| EP (1) | EP2945641B1 (enExample) |
| JP (3) | JP6719209B2 (enExample) |
| CN (1) | CN105377282B (enExample) |
| BR (1) | BR112015016817B1 (enExample) |
| CA (1) | CA2897348C (enExample) |
| CY (1) | CY1122822T1 (enExample) |
| DK (1) | DK2945641T3 (enExample) |
| ES (1) | ES2774729T3 (enExample) |
| GB (1) | GB201300707D0 (enExample) |
| HR (1) | HRP20200351T1 (enExample) |
| LT (1) | LT2945641T (enExample) |
| PL (1) | PL2945641T3 (enExample) |
| PT (1) | PT2945641T (enExample) |
| SI (1) | SI2945641T1 (enExample) |
| WO (1) | WO2014111344A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201300707D0 (en) * | 2013-01-15 | 2013-02-27 | Novartis Ag | Compounds and processes |
| US20190054127A1 (en) * | 2016-03-04 | 2019-02-21 | Euglena Co., Ltd. | Antiviral agent and antiviral food |
| CN110366428B (zh) | 2016-12-30 | 2024-05-17 | Vaxcyte公司 | 具有非天然氨基酸的多肽-抗原缀合物 |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| WO2019151128A1 (ja) * | 2018-02-05 | 2019-08-08 | 国立大学法人 宮崎大学 | 細胞標識剤及び細胞標識キット |
| WO2019240219A1 (ja) | 2018-06-14 | 2019-12-19 | 持田製薬株式会社 | 新規な架橋アルギン酸 |
| WO2020010016A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Self-adjuvanted immunogenic conjugates |
| KR20230052958A (ko) | 2020-08-19 | 2023-04-20 | 박사이트, 인코포레이티드 | 운반-단백질 폴리삭카라이드 접합 방법 |
| MX2023013434A (es) * | 2021-05-28 | 2023-12-12 | Pfizer | Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos. |
| JP7804631B2 (ja) * | 2022-11-22 | 2026-01-22 | ファイザー・インク | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2616180T3 (es) | 2002-03-26 | 2017-06-09 | Glaxosmithkline Biologicals Sa | Sacáridos modificados con estabilidad mejorada en agua para su uso como medicamento |
| MX2007005202A (es) * | 2004-11-01 | 2007-07-09 | Brigham & Womens Hospital | Polisacaridos de estreptococo modificados y usos de los mismos. |
| GB0502095D0 (en) * | 2005-02-01 | 2005-03-09 | Chiron Srl | Conjugation of streptococcal capsular saccharides |
| EP2222341B1 (en) * | 2007-11-21 | 2015-02-25 | University Of Georgia Research Foundation, Inc. | Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| ITVI20090234A1 (it) * | 2009-09-25 | 2011-03-26 | Termotecniche Fraccaro S R L Off | Dispositivo per il riscaldamento di ambienti ad alta efficienza energetica, nonche' sistema riscaldante comprendente tale dispositivo |
| CA2785410A1 (en) * | 2009-12-23 | 2011-06-30 | Carlos F. Barbas, Iii | Tyrosine bioconjugation through aqueous ene-like reactions |
| EP2563753B9 (en) | 2010-04-27 | 2016-07-06 | SynAffix B.V. | Fused cyclooctyne compounds and their use in metal-free click reactions |
| WO2012017701A1 (ja) * | 2010-08-05 | 2012-02-09 | 株式会社ミュージックゲート | いびき防止マスク |
| GB201101665D0 (en) * | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
| WO2012047663A2 (en) | 2010-09-27 | 2012-04-12 | University Of Georgia Reaserch Foundation, Inc. | Methods including latent 1,3-dipole-functional compounds and materials prepared thereby |
| US20120208722A1 (en) * | 2010-10-19 | 2012-08-16 | Richard Dluhy | Surface enhanced raman spectroscopy platforms and methods |
| PL2721045T3 (pl) | 2011-06-20 | 2017-11-30 | Radiomedix Inc. | Kompozycie, metody syntezy i zastosowanie węglowodanowych środków ukierunkowanych |
| BR112014013250A2 (pt) * | 2011-12-01 | 2019-09-24 | Angiochem Inc | compostos com enzima alvo e usos dos mesmos |
| GB201300707D0 (en) * | 2013-01-15 | 2013-02-27 | Novartis Ag | Compounds and processes |
-
2013
- 2013-01-15 GB GBGB1300707.5A patent/GB201300707D0/en not_active Ceased
-
2014
- 2014-01-13 CA CA2897348A patent/CA2897348C/en active Active
- 2014-01-13 JP JP2015552077A patent/JP6719209B2/ja active Active
- 2014-01-13 CN CN201480012960.8A patent/CN105377282B/zh active Active
- 2014-01-13 SI SI201431496T patent/SI2945641T1/sl unknown
- 2014-01-13 PT PT147006027T patent/PT2945641T/pt unknown
- 2014-01-13 LT LTEP14700602.7T patent/LT2945641T/lt unknown
- 2014-01-13 BR BR112015016817-5A patent/BR112015016817B1/pt active IP Right Grant
- 2014-01-13 EP EP14700602.7A patent/EP2945641B1/en active Active
- 2014-01-13 HR HRP20200351TT patent/HRP20200351T1/hr unknown
- 2014-01-13 ES ES14700602T patent/ES2774729T3/es active Active
- 2014-01-13 PL PL14700602T patent/PL2945641T3/pl unknown
- 2014-01-13 DK DK14700602.7T patent/DK2945641T3/da active
- 2014-01-13 US US14/760,916 patent/US11135300B2/en active Active
- 2014-01-13 WO PCT/EP2014/050483 patent/WO2014111344A1/en not_active Ceased
-
2018
- 2018-12-28 JP JP2018246761A patent/JP2019073528A/ja not_active Withdrawn
-
2020
- 2020-03-13 CY CY20201100223T patent/CY1122822T1/el unknown
- 2020-03-23 JP JP2020050828A patent/JP7036854B2/ja active Active
-
2021
- 2021-05-14 US US17/320,482 patent/US12409231B2/en active Active
-
2025
- 2025-08-08 US US19/294,579 patent/US20260027216A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016506905A5 (enExample) | ||
| WO2008083174A3 (en) | Compositions and methods for the treatment of infections and tumors | |
| HRP20200351T1 (hr) | Cikloalkinski derivati saharida | |
| WO2018098269A3 (en) | Peptide-containing linkers for antibody-drug conjugates | |
| WO2009082818A8 (en) | Novel c-21-keto lupane derivatives preparation and use thereof | |
| SG158870A1 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
| WO2009082819A8 (en) | Novel lupane derivatives | |
| EP3318562A3 (en) | Benzylbenzene derivatives and methods of use | |
| WO2009106980A3 (en) | Indazole derivatives | |
| JP2012528865A5 (enExample) | ||
| ATE409048T1 (de) | Pharmazeutisch aktive oligosaccharid-conjugate | |
| WO2007062107A3 (en) | Immunostimulatory oligoribonucleotides | |
| CL2008003153A1 (es) | Compuestos espiro condensados, agonistas de gpr40: composicion farmaceutica que comprende a uno de los compuestos; y el uso de los compuestos en la preparacion de medicamentos para el tratamiento de la diabetes, hiperglicemia, alteracion de tolerancia a la glucosa en ayuna, entre otras. | |
| WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
| RU2015118581A (ru) | Лиофилизированные препараты мелфалана флуфенамида | |
| WO2009088838A3 (en) | Triarylmethane analogs and their use in treating cancers | |
| JP2017505777A5 (enExample) | ||
| WO2015066053A3 (en) | Targeted therapeutics | |
| US11702443B2 (en) | Therapeutic agents and methods | |
| Tabakmakher et al. | Normonanchocidins A, B and D, new pentacyclic guanidine alkaloids from the Far-Eastern marine sponge Monanchora pulchra | |
| RU2013136895A (ru) | Новое бициклическое соединение или его соль | |
| RU2012150501A (ru) | Противораковые стероидные лактоны, ненасыщенные в положении 7(8) | |
| AR048336A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| WO2015009731A3 (en) | Azacyclic constrained analogs of fty720 | |
| WO2009102808A3 (en) | Doxorubicin adjuvants to reduce toxicity and methods for using the same |